ÌÇÐÄ´«Ã½

Skip to main content
 
Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

See our updated masking policy

ÌÇÐÄ´«Ã½

Mycobacteria in Organ Transplant Recipients.

ÌÇÐÄ´«Ã½

Mycobacteria in Organ Transplant Recipients. Infectious disease clinics of North America Narsana, N., Alejandra Perez, M., Subramanian, A. 2023

Abstract

This review describes the epidemiology and risk factors of tuberculosis (TB) in solid organ transplant recipients. We discuss the pre-transplant screening for risk of TB and management of latent TB in this population. We also discuss the challenges of management of TB and other difficult to treat mycobacteria such as Mycobacterium abscessus and Mycobacterium avium complex. The drugs for the management of these infections include rifamycins which have significant drug interactions with immunosuppressants and must be monitored closely.

View details for

View details for